150 related articles for article (PubMed ID: 12548574)
1. Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications.
Chung LW
Cancer; 2003 Feb; 97(3 Suppl):772-8. PubMed ID: 12548574
[TBL] [Abstract][Full Text] [Related]
2. Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting.
Sung SY; Chung LW
Differentiation; 2002 Dec; 70(9-10):506-21. PubMed ID: 12492493
[TBL] [Abstract][Full Text] [Related]
3. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
5. Development of an animal model for prostate cancer cell metastasis to adult human bone.
Tsingotjidou AS; Zotalis G; Jackson KR; Sawyers C; Puzas JE; Hicks DG; Reiter R; Lieberman JR
Anticancer Res; 2001; 21(2A):971-8. PubMed ID: 11396190
[TBL] [Abstract][Full Text] [Related]
6. The role of the stromal microenvironment in prostate cancer.
Condon MS
Semin Cancer Biol; 2005 Apr; 15(2):132-7. PubMed ID: 15652458
[TBL] [Abstract][Full Text] [Related]
7. The role of tumor microenvironment in prostate cancer bone metastasis.
Morrissey C; Vessella RL
J Cell Biochem; 2007 Jul; 101(4):873-86. PubMed ID: 17387734
[TBL] [Abstract][Full Text] [Related]
8. Stromal factors involved in prostate carcinoma metastasis to bone.
Cooper CR; Chay CH; Gendernalik JD; Lee HL; Bhatia J; Taichman RS; McCauley LK; Keller ET; Pienta KJ
Cancer; 2003 Feb; 97(3 Suppl):739-47. PubMed ID: 12548571
[TBL] [Abstract][Full Text] [Related]
9. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone.
Wang R; Xu J; Juliette L; Castilleja A; Love J; Sung SY; Zhau HE; Goodwin TJ; Chung LW
Semin Cancer Biol; 2005 Oct; 15(5):353-64. PubMed ID: 15982899
[TBL] [Abstract][Full Text] [Related]
11. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
[TBL] [Abstract][Full Text] [Related]
12. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
13. Understanding the biology of bone metastases: key to the effective treatment of prostate cancer.
Logothetis CJ; Navone NM; Lin SH
Clin Cancer Res; 2008 Mar; 14(6):1599-602. PubMed ID: 18347159
[TBL] [Abstract][Full Text] [Related]
14. In vivo models of prostate cancer metastasis to bone.
Singh AS; Figg WD
J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
[TBL] [Abstract][Full Text] [Related]
15. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
16. Modulation of prostate cancer growth in bone microenvironments.
Edlund M; Sung SY; Chung LW
J Cell Biochem; 2004 Mar; 91(4):686-705. PubMed ID: 14991761
[TBL] [Abstract][Full Text] [Related]
17. Gene promoter methylation in prostate tumor-associated stromal cells.
Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
[TBL] [Abstract][Full Text] [Related]
18. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
Loberg RD; Logothetis CJ; Keller ET; Pienta KJ
J Clin Oncol; 2005 Nov; 23(32):8232-41. PubMed ID: 16278478
[TBL] [Abstract][Full Text] [Related]
20. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
Power CA; Pwint H; Chan J; Cho J; Yu Y; Walsh W; Russell PJ
Prostate; 2009 Nov; 69(15):1613-23. PubMed ID: 19585491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
